Immediate-release tablet formulation of rebamipide and a pharmacokinetic study in healthy human subjects
Int. Journal of Clinical Pharmacology and Therapeutics · 2023
DOI: 10.5414/cp204329 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2023. Verfasst von Yong-Hoon Won und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Therapeutic Equivalency.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Won, Y. H., Goo, Y. T., Sin, G. H., Hong, S. H., Kim, C. H., Kim, M. J., Lee, T. H., & Choi, Y. W. (2023). Immediate-release tablet formulation of rebamipide and a pharmacokinetic study in healthy human subjects. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204329
Vancouver
Won YH, Goo YT, Sin GH, Hong SH, Kim CH, Kim MJ, et al. Immediate-release tablet formulation of rebamipide and a pharmacokinetic study in healthy human subjects. Int. Journal of Clinical Pharmacology and Therapeutics. 2023. doi:10.5414/cp204329
BibTeX
@article{Won2023,
author = {Won, Yong-Hoon and Goo, Yoon Tae and Sin, Gi Hyeong and Hong, Sun Ho and Kim, Chang Hyun and Kim, Min-Ju and Lee, Tae Hwa and Choi, Young Wook},
title = {Immediate-release tablet formulation of rebamipide and a pharmacokinetic study in healthy human subjects},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2023},
doi = {10.5414/cp204329}
}
EUVIMED